Dr. Laura Williams Goff, MD

Dr. Goff practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Goff's NPI, 1023165909, was assigned on January 4, 2007. Dr. Goff graduated from University of Texas Medical School at San Antonio in 2001. Dr. Goff holds Tennessee license MD38846.

Dr. Goff's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Goff's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt Health and Williamson Medical Center Walk In Clinic Franklin. Dmand AI also links Dr. Goff to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goff practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Goff's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Goff is licensed in Tennessee.

CMS data shows 243 Medicare services from Dr. Goff across 5 procedure codes in 2024, for 118 Medicare patients. Medicare paid $21,543 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Goff in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goff's median patient age at 70, with 54% women.

In 2024, Dr. Goff wrote 235 Medicare Part D claims for 61 patients. 76% of them were for generic drugs. CMS names the drug for 57 of them, across 4 drugs with 11 or more claims each, at $12,880 in total drug cost. In 2023, CMS named 54 claims across 4 drugs.

Dr. Goff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goff as offering telehealth.

Dmand AI links 43 papers to Dr. Goff, published from 2012 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Biliary Tract Neoplasms and Antineoplastic Agents. Dr. Goff has published most often in Clin Cancer Res. Dr. Goff's most frequent co-authors are Jordan D. Berlin, MD, Rajiv Agarwal and Kristen Keon Ciombor, MD.

Dmand AI links Dr. Goff to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Biliary Tract Neoplasms, Stomach Neoplasms and Biliary Tract Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Goff that name 2 trials.

CMS Open Payments shows 52 general payments to Dr. Goff from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Merck Sharp & Dohme Corporation paid the most, $7,600. It also lists 3 research payments totaling $969 from 2016 to 2017, naming 2 clinical trials.

Dr. Goff graduated from University of Texas Medical School at San Antonio in 2001.